Health · 14 hours ago
Dementia experts urge ministers to lift NHS ban on Alzheimer's drugs
Photo by Towfiqu barbhuiya on Pexels
Thirty-eight leading specialists have written to the Health Secretary, Yvette Cooper, asking her to help get two new Alzheimer's drugs on the NHS. In 2024, lecanemab and donanemab received their licences in Britain following trials that demonstrated a reduction in cognitive decline of approximately one-third. Nevertheless, NICE, the health spending watchdog, declined to approve their standard application, deeming the advantages insufficient to warrant the expenditure.
Reported by The Telegraph · How we write briefs